Canaccord Genuity Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Updating Model
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Hi Tech Pharmacal (NASDAQ: HITK) price target of $45.00.
Analyst, Randall Stanicky, said, "Bottom line: we lower EPS estimates but make no change to our rating or target which implies ~ 14% upside from today’s close. Model update – lower EPS largely on gross margin assumptions We make several adjustments post the quarter and catch-up with management, with the net being lower EPS estimates through fiscal 2016 – though less so in the out-years. We leave potential for upward revision from: (1) less competitive fluticasone impact; (2) pipeline conversion we have not modeled; and (3) business development where focus remains."
For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.
Shares of Hi Tech Pharmacal closed at $39.63 yesterday.
Analyst, Randall Stanicky, said, "Bottom line: we lower EPS estimates but make no change to our rating or target which implies ~ 14% upside from today’s close. Model update – lower EPS largely on gross margin assumptions We make several adjustments post the quarter and catch-up with management, with the net being lower EPS estimates through fiscal 2016 – though less so in the out-years. We leave potential for upward revision from: (1) less competitive fluticasone impact; (2) pipeline conversion we have not modeled; and (3) business development where focus remains."
For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.
Shares of Hi Tech Pharmacal closed at $39.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Deere (DE) PT Raised to $585 at JPMorgan
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
